Marpai, Inc. (MRAI): R&D Expense
$7.0K
Year ended 2025-12-31
-87.6%
3-year compound annual growth
-66.9%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.0K | -75.9% | 2026-03-25, From 2025-01-01 |
| 2024-12-31 | $29.0K | -97.8% | 2026-03-25, From 2024-01-01 |
| 2023-12-31 | $1.31M | -64.6% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $3.71M | +113.8% | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | $1.73M | -1.8% | 2023-07-27, From 2021-01-01 |
| 2020-12-31 | $1.77M | n/a | 2022-03-30, From 2020-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Marpai, Inc. (MRAI) | 2025-12-31 | $7.0K | -75.9% |
| Cryo Cell International Inc (CCEL) | 2025-11-30 | $376.3K | -69.7% |
| Viemed Healthcare, Inc. (VMD) | 2025-12-31 | $3.02M | -1.7% |
| BioRestorative Therapies, Inc. (BRTX) | 2025-12-31 | $10.09M | +50.5% |
| Progyny, Inc. (PGNY) | 2025-12-31 | $9.50M | n/a |
Compare MRAI, CCEL, VMD, BRTX side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗